Literature DB >> 12406438

Pathogenesis of steatohepatitis.

C P Day1.   

Abstract

Understanding the pathogenesis of non-alcoholic steatohepatitis has recently assumed great importance with the recognition that it has the potential to progress to fibrosis and cirrhosis. The 'two-hit' model of pathogenesis was proposed in 1998, with the first 'hit' - steatosis - increasing the sensitivity of the liver to the second 'hits' mediating liver injury. The main aim of this chapter is to review this model in the light of studies that have been published over the subsequent 4 years. Particular attention will be focused on the role of insulin resistance and recent advances in our understanding of the basic cellular mechanisms linking obesity and insulin resistance. Based on this information I will propose a modification of the two-hit model that places more emphasis on the role of free fatty acids. This model will provide the basis for further research and enable the rational design of treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12406438     DOI: 10.1053/bega.2002.0333

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  126 in total

1.  Noninvasive Diagnosis of NASH and Liver Fibrosis Within the Spectrum of NAFLD.

Authors:  Naim Alkhouri; Arthur J McCullough
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-10

Review 2.  Pathogenesis of alcoholic liver disease: interactions between parenchymal and non-parenchymal cells.

Authors:  Jessica I Cohen; Laura E Nagy
Journal:  J Dig Dis       Date:  2011-02       Impact factor: 2.325

3.  Symptoms of obstructive sleep apnea in patients with nonalcoholic fatty liver disease.

Authors:  Harminder Singh; Richard Pollock; Julia Uhanova; Meir Kryger; Kim Hawkins; Gerald Y Minuk
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

Review 4.  Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease.

Authors:  Silvia Marinho Ferolla; Geyza Nogueira de Almeida Armiliato; Cláudia Alves Couto; Teresa Cristina Abreu Ferrari
Journal:  World J Hepatol       Date:  2015-03-27

5.  Effects of canagliflozin, an SGLT2 inhibitor, on hepatic function in Japanese patients with type 2 diabetes mellitus: pooled and subgroup analyses of clinical trials.

Authors:  Yuya Seko; Yoshio Sumida; Kazuyo Sasaki; Yoshito Itoh; Hiroaki Iijima; Toshio Hashimoto; Shinichi Ishii; Nobuya Inagaki
Journal:  J Gastroenterol       Date:  2017-07-01       Impact factor: 7.527

6.  N-acetylcysteine attenuates oxidative stress and liver pathology in rats with non-alcoholic steatohepatitis.

Authors:  Duangporn Thong-Ngam; Suchittra Samuhasaneeto; Onanong Kulaputana; Naruemon Klaikeaw
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

7.  Anthropometric and metabolic characteristics in children with clinically diagnosed nonalcoholic fatty liver disease.

Authors:  Diana R Mager; Simon Ling; Eve A Roberts
Journal:  Paediatr Child Health       Date:  2008-02       Impact factor: 2.253

8.  Induction of liver steatosis and lipid droplet formation in ATF6alpha-knockout mice burdened with pharmacological endoplasmic reticulum stress.

Authors:  Keisuke Yamamoto; Kazuna Takahara; Seiichi Oyadomari; Tetsuya Okada; Takashi Sato; Akihiro Harada; Kazutoshi Mori
Journal:  Mol Biol Cell       Date:  2010-07-14       Impact factor: 4.138

9.  Carbon tetrachloride-induced liver disease in rats: the potential effect of supplement oils with vitamins E and C on the nutritional status.

Authors:  Rasha S A Ismail; Ashraf A A El-Megeid; Aly R Abdel-Moemin
Journal:  Ger Med Sci       Date:  2009-06-30

Review 10.  Pathogenesis of non-alcoholic fatty liver disease.

Authors:  J K Dowman; J W Tomlinson; P N Newsome
Journal:  QJM       Date:  2009-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.